FDA v. Alliance Hippocratic Medicine
Supreme Court of the United States · March 26, 2024
Oral argument before the U.S. Supreme Court in FDA v. Alliance for Hippocratic Medicine on challenges to FDA’s 2016 and 2021 regulatory changes for mifepristone, with extended questioning on Article III standing, agency deference, safety evidence, REMS changes, and remedial scope.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.